Indeed, both TSPO activation and reactivation of p53 function, through the dissociation from its physiological inhibitor, MDM2, have largely been demonstrated to act as apoptosis inducers across multiple cell types, including glioma cells8, 11, 12, 15, 16. This evidence concerns the gene MDM2 and central nervous system cancer.